Answers are grounded in this paper and cite their sources.
Serum plasmalogen levels have been implicated in AD. Plasmalogen biosynthesis involves two peroxisome-dependent steps: 1), the sn-1 fatty alcohol is synthesized from acetyl-CoA derived exclusively from intra-peroxisomal β-oxidation of very long chain fatty acids; and 2), this alcohol is used to synthesize 1-alkylglycerolphosphate which subsequently enters phospholipid-independent and plasmalogen-specific metabolic pathways outside the peroxisome. Peroxisomal β-oxidation and plasmalogen biosynthesis was investigated in participants in the Religious Orders Study and Rush Memory and Aging Project as potential biomarkers for AD. Stable isotope mass spectrometry was used to comprehensively measure phosphatidylcholine, phosphatidylethanolamine, plasmalogens, and lyso-phosphatidylcholine species in the serum in 1255 older persons. All subjects were without known dementia at enrollment and underwent comprehensive clinical evaluation on an annual basis. Analyses were based on the cognitive assessment from the most recent clinical evaluation proximate to the blood draw. Peroxisomal β-oxidation status was measured by calculating the ratio of a peroxisomal β-oxidation product 20:5 (eicosapentaenoic acid) to a peroxisomal β-oxidation precursor 22:4 (adrenic acid). Plasmalogen biosynthesis status was determined by measuring individual phospholipid species. All models were adjusted for age, sex, education, and APOE status. In cross-sectional analyses, higher peroxisomal β-oxidation levels, and higher plasmalogen levels were associated with better cognition (r=0.59 and r=0.34, p's<0.001), and a reduced Odds Ratio (OR) of AD (OR=0.08 and OR=0.22, p<0.001 and p=0.03); APOE ε4 was associated with lower cognition (r=-0.35, p<0.001) and an increased OR of AD (OR=2.8, p<0.001). In stratified analyses the relation of both peroxisomal β-oxidation levels and plasmalogen levels on the odds of AD differed by APOE genotype (Figure 1, p's<0.001). In APOE ε3/3 persons AD OR=0.08 and OR=0.08 and in ε3/4 persons AD OR=0.09 and OR=0.11 for higher peroxisomal β-oxidation levels and higher plasmalogen levels, respectively (p's<0.01). By contrast, no effect was observed in APOE ε2/3 persons.
No takes yet. Share an insight, caveat, or question.
Goodenowe et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: